Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide

Monir Moradzadeh Khiavi, Ahamd Rostami, Hamed Hamishekar, Mehran Mesgari Abassi, Amirala Aghbali, Roya Salehi, Bita Abdollahi, Soheila Fotoohi, Mahmud Sina

Adv Pharm Bull. 2015;5(2): 209-216. doi: 10.15171/apb.2015.029

PMCID: PMC4517077 PMID: 26236659 Scopus ID: 84930402125

Article

PDF

XML

Cited By:

10

1

7

Original Research

2. pH-Triggered Magnetic-Chitosan Nanogels (MCNs) For Doxorubicin Delivery: Physically vs. Chemically Cross Linking Approach

Somayeh Sadighian, Hassan Hosseini-Monfared*, Kobra Rostamizadeh, Mehrdad Hamidi

Adv Pharm Bull. 2015;5(1): 115-120. doi: 10.5681/apb.2015.016

PMCID: PMC4352213 PMID: 25789228 Scopus ID: 84924577649

Article

PDF

XML

Cited By:

35

5

Original Research

3. Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells

Simin Sharifi, Jaleh Barar, Mohammad Saeid Hejazi*, Nasser Samadi*

Adv Pharm Bull. 2015;5(3): 351-359. doi: 10.15171/apb.2015.049

PMCID: PMC4616902 PMID: 26504757 Scopus ID: 84983573942

Article

PDF

XML

Cited By:

95

36

98

Research Article

4. Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats

Nasser Razmaraii, Hossein Babaei*, Alireza Mohajjel Nayebi, Gholamreza Assadnassab, Javad Ashrafi Helan, Yadollah Azarmi

Adv Pharm Bull. 2016;6(3): 423-433. doi: 10.15171/apb.2016.055

PMCID: PMC5071806 PMID: 27766227 Scopus ID: 84995564006

Article

PDF

XML

Cited By:

22

7

22

Research Article

5. Evaluation of Flavonoid Derivative and Doxorubicin Effects in Lung Cancer Cells (A549) Using Differential Pulse Voltammetry Method

Mohammad Amjadi , Jalal Mohammadi Khoshraj* , Mir Reza Majidi , Behzad Baradaran , Miguel de la Guardia

Adv Pharm Bull. 2018;8(4): 637-642. doi: 10.15171/apb.2018.072

PMCID: PMC6311643 PMID: 30607336 Scopus ID: 85057755414

Article

PDF

XML

Cited By:

10

3

11

Research Article

6. The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells

Riris Istighfari Jenie , Sri Handayani , Ratna Asmah Susidarti, Linar Zalinar Udin, Edy Meiyanto*

Adv Pharm Bull. 2018;8(3): 507-516. doi: 10.15171/apb.2018.059

PMCID: PMC6156471 PMID: 30276148 Scopus ID: 85052581155

Article

PDF

XML

Cited By:

20

8

24

Research Article

7. Enhanced Intestinal Permeation of Doxorubicin Using Chitosan Nanoparticles

Marziyeh Zare , Soliman Mohammadi Samani , Zahra Sobhani*

Adv Pharm Bull. 2018;8(3): 411-417. doi: 10.15171/apb.2018.048

PMCID: PMC6156480 PMID: 30276137 Scopus ID: 85052570825

Article

PDF

XML

Cited By:

16

8

24

Research Article

8. Evaluation of the Cytotoxic and Apoptogenic Effects of Glabridin and Its Effect on Cytotoxicity and Apoptosis Induced by Doxorubicin Toward Cancerous Cells

Masoud Modarresi , Marziyeh Hajialyani , Narges Moasefi , Farahnaz Ahmadi , Leila Hosseinzadeh*

Adv Pharm Bull. 2019;9(3): 481-489. doi: 10.15171/apb.2019.057

PMCID: PMC6773930 PMID: 31592119 Scopus ID: 85070472005

Article

PDF

XML

Cited By:

5

2

9

Research Article

9. Cytotoxic and Radiosensitizing Effects of Folic Acid-ConjugatedGold Nanoparticles and Doxorubicin on Colorectal Cancer Cells

Behnam Heshmatian , Zhaleh Behrouzkia, Mahshid Mohammadian, Zhino Moradi, Zeinab Mohammadi* , Reza Zohdi Aghdam

Adv Pharm Bull. 2022;12(4): 772-779. doi: 10.34172/apb.2022.079

PMCID: PMC9675912 PMID: 36415636 Scopus ID: 85140275633

Article

PDF

Full Text

XML

Cited By:

0

1

Research Article

10. High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients

Ami Ashariati Prayogo* , Satriyo Dwi Suryantoro, Merlyna Savitri, Winona May Hendrata , Andi Yasmin Wijaya , Budi Susetyo Pikir

Adv Pharm Bull. 2022;12(1): 163-168. doi: 10.34172/apb.2022.017

PMCID: PMC9012930 PMID: 35517883 Scopus ID: 85127105583

Article

PDF

Full Text

XML

Cited By:

0

1

0

Research Article

11. Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin

Abbas Soltani , Parvaneh Pakravan*

Adv Pharm Bull. 2023;13(2): 301-308. doi: 10.34172/apb.2023.033

PMCID: PMC10278217 PMID: 37342367

Article

PDF

Full Text

XML

Cited By:

0

4

Research Article

12. Liposome-Fe3 O4-Doxorubicin Mediated Treatment of Melanoma Tumors

Azalia Azlegini , Sirus Javadpour* , Mohamad Ebrahim Bahrololoom

Adv Pharm Bull. 2023;13(2): 309-316. doi: 10.34172/apb.2023.034

PMCID: PMC10278224 PMID: 37342384

Article

PDF

Full Text

XML

Cited By:

0

2